Icon

Riomet - (500 mg/5 mL; Solution, Oral)

Metformin Hydrochloride Sun Pharma
500 mg/5 mL; Solution, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
None
Less Than 5
Less Than 5
Indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus.
Yes
*** ******* *** ********** ******** ** *******(*********) ** ****. ** **** ******* ******* ********* ****** ** *** ******* *** ********** ***** ** ****** ** *** **** ***** *** ********* ****-****** ****** *** **** ********** ****** ********. ***** ** ** *********** ********* ** **** *** ******* ******* ******* *** ****. ******* ******* *** ***** ******** ** *** *** ***** *** ******* ********* ******* ** ***. ******** ** *** ***** ** **** **** ** **** ****** '***(*** *, ****). ****** *** ****** ** ** ****** ****, ********** *** ********* **** ******** ***** *** ***** ** ********* *** *** *****. ** ****** ******** ** ****** ** ****** **** **** *.*. * ***** ****** *** **** **** ** *** ***** ****** *** *** ******* *** ******* *** ****. ** ** ********* ** **** **** *** ******* ** ***** ******** ** **** *** ***** **** ** ** ***** ** *** ****.
Riomet Patent 1
******** ******* ***** *** ** **
********** *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******** *** \ *** *** **, **** **** ******* ***** ******** *** *** **** ** ** ******** ******** ** *** **, ****
********** ** \ ** **** *, **** ******* ******** ******** ** *** ****
  1. *** **, **** : ******** ******** *** ****** ***** *** **** ** **** ****** '***(**** **, ****).
  2. *** **, **** : *** ****** ***** * **** ******* ******** ** ******** ***** ** ********.
  3. *** **, **** : ***** ******** **** *** *** ********* **** ********* ************* ******** *** **** ********, *** **, *** **, *** * * ** ******** *** ********** ** ** ****
  4. *** **, **** : ********** ******** *** ****** ***** *** **** ** **** ****** '***(**** **, ****).
  5. *** *, **** : *** ****** ***** * **** ******* ********** **** ****** '***(**** **, ****).
  6. *** **, **** : ********** ********* **** *** ******, ***** *** ***** ** ********* *** *** *****.
  7. *** *, **** : ********** ********* **** ******** *** ***** ***** **** '***(**** **, ****) ****** ** *** ********* ** ******** ******.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.